These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 21821000

  • 1. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K, Lee AY, Kwon YK, Kwon H.
    Biochem Biophys Res Commun; 2011 Aug 26; 412(2):328-33. PubMed ID: 21821000
    [Abstract] [Full Text] [Related]

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar 26; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 3. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E.
    Gynecol Oncol; 2004 Jul 26; 94(1):40-7. PubMed ID: 15262117
    [Abstract] [Full Text] [Related]

  • 4. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.
    Reprod Sci; 2007 Jan 26; 14(1):20-8. PubMed ID: 17636212
    [Abstract] [Full Text] [Related]

  • 5. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M.
    Oncogene; 1996 Sep 05; 13(5):1027-35. PubMed ID: 8806692
    [Abstract] [Full Text] [Related]

  • 6. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 05; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 7. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug 05; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 9. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 07; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 10. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ.
    Clin Cancer Res; 2007 Jan 01; 13(1):132-8. PubMed ID: 17200347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Peñalver M, Averette HE.
    Gynecol Oncol; 1997 Jan 01; 64(1):18-25. PubMed ID: 8995542
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS.
    Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug 21; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
    Chen L, Wu YY, Liu P, Wang J, Wang G, Qin J, Zhou J, Zhu J.
    Med Oncol; 2011 Dec 21; 28 Suppl 1():S528-39. PubMed ID: 21222176
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K, Dannenberg AJ.
    Cancer Res; 2007 Apr 15; 67(8):3976-85. PubMed ID: 17440114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.